Malignant mesothelioma: Canadian perspective and research directions

Since the 1960s, the incidence of malignant mesothelioma in Canada has increased dramatically because of work-related asbestos exposures. Treatment options are limited. Although chemotherapy is now an accepted standard in the management of advanced disease, uncertainty surrounds the roles of radical...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, C.W., Martin, J., MacRae, R., Tsao, M.S., Nguyen, E., Johnston, M., Baas, P., Laurie, S., Feld, R., Murray, N., Shepherd, F.A.
Formato: Texto
Lenguaje:English
Publicado: Multimed Inc. 2008
Materias:
Meeting Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365488/
Descripción
Sumario:Since the 1960s, the incidence of malignant mesothelioma in Canada has increased dramatically because of work-related asbestos exposures. Treatment options are limited. Although chemotherapy is now an accepted standard in the management of advanced disease, uncertainty surrounds the roles of radical surgery and radiation. In March 2007, a symposium was held in Vancouver, B.C., to review the current approach to malignant mesothelioma in Canada and to discuss development of a national clinical research strategy.

Ejemplares similares